Improving healthcare access and outcomes for patients with inflammatory bowel disease
Official title: Developing and applying common data elements to enhance clinical and translational research, healthcare access and outcomes in inflammatory bowel disease
Funded at Icahn School of Medicine at Mount Sinai · NIH-11159202 · Data updated 2026-11-12
This study is working to improve how we understand and treat inflammatory bowel diseases like Crohn's and ulcerative colitis, especially for people from diverse backgrounds, by gathering important health information to help doctors find and help patients better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $491,500 |
| NIH project number | 3U24DK062429-25S1 |
| Project ID | NIH-11159202 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with inflammatory bowel disease, particularly those from LatinX and Black populations.
✕Less likely to help
Patients with inflammatory bowel disease who are not part of the targeted diverse populations may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing clinical and translational research for inflammatory bowel diseases (IBD), specifically Crohn's disease and ulcerative colitis. It aims to develop common data elements that will improve patient recruitment and outcomes, particularly among diverse populations such as LatinX and Black individuals. By analyzing genetic and phenotypic data, the research seeks to address disparities in diagnosis and treatment access. Patients will be engaged through established protocols to ensure a representative cohort that reflects the diversity of IBD patients.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare access and better treatment outcomes for patients with inflammatory bowel disease.
How similar studies have gone: Previous research has shown success in enhancing patient recruitment and outcomes through similar collaborative approaches in diverse populations.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Cho, Judy H. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Cho, Judy H.
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial Talks: How Energy Networks Shape Inflammatory Bowel Disease
Aimed at people with inflammatory bowel disease (IBD), this project explores how tiny cell powerhouses in the gut may go out of balance and contribute to IBD, with the goal of restoring energy and reducing disease symptoms.
-
Mn in inflammatory bowel disease: how manganese and genes may shape gut inflammation
This grant studies how the mineral manganese and a specific gene variant may influence inflammatory bowel disease in people of different ages.
-
AI-Enhanced Virtual Reality CBT to Reduce Anxiety for IBD Patients
A home-based VR and AI-powered cognitive behavioral therapy program is being tested to help people with inflammatory bowel disease feel less anxious and improve their quality of life.
-
Gasdermin-based epithelial function in inflammatory bowel disease
A funding opportunity that explores how gasdermin proteins affect the lining of the gut and may influence inflammatory bowel disease.
-
Intestinal chondroitin sulfate glycosaminoglycans and their role in inflammatory bowel disease
A clinician-scientist mentoring program aims to advance understanding of how intestinal sugar molecules called chondroitin sulfate glycosaminoglycans influence inflammatory bowel disease and patient care.
-
Improving IBD outcomes through community awareness, referrals, and education
A U01 grant will support programs to raise awareness, improve referrals, and educate patients and clinicians about inflammatory bowel disease to improve diagnosis and care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.